Published in Heart on January 01, 1999
Randomised trials of new procedures: problems and pitfalls. Heart (1997) 1.19
Minimally invasive direct coronary artery bypass: too young for a trial. Heart (1997) 1.07
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet (1996) 6.48
Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet (1999) 5.15
Availability of transplantable organs from brain stem dead donors in intensive care units. BMJ (1991) 2.84
Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med (1991) 2.45
Early complications after dual chamber versus single chamber pacemaker implantation. Pacing Clin Electrophysiol (1994) 2.45
The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med (1995) 2.42
Organs for transplantation. BMJ (1989) 2.42
Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol (1983) 2.34
Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet (1991) 2.30
Cardiac transplantation in perspective for the future. Survival, complications, rehabilitation, and cost. J Thorac Cardiovasc Surg (1982) 2.26
Xenografting: probability, possibility, or pipe dream? Lancet (1993) 2.08
Prospective study of quality of life before and after coronary artery bypass grafting. BMJ (1991) 2.03
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science (2000) 2.03
Balloon mitral valvuloplasty employing double transseptal puncture. Cathet Cardiovasc Diagn (1998) 2.01
Coronary angiography from the radial artery--experience, complications and limitations. Int J Cardiol (1998) 1.95
Flexible random-effects models using Bayesian semi-parametric models: applications to institutional comparisons. Stat Med (2007) 1.90
Cardio-oesophageal reflex in humans as a mechanism for "linked angina'. Eur Heart J (1996) 1.84
Noninvasive assessment of left internal mammary artery graft patency using transthoracic echocardiography. Circulation (1995) 1.80
Toxoplasmosis in heart and heart and lung transplant recipients. J Clin Pathol (1989) 1.78
Inoue balloon mitral valvuloplasty: long-term clinical and echocardiographic follow-up of a predominantly unfavourable population. Eur Heart J (2000) 1.77
Heart-lung transplantation for cystic fibrosis. Lancet (1988) 1.70
Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms. Eur Heart J (1997) 1.69
Medical oaths and declarations. BMJ (2001) 1.67
The use of hospital admission data as a measure of outcome in clinical studies of heart failure. Eur Heart J (2003) 1.64
Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant (1998) 1.63
Late complications following permanent pacemaker implantation or elective unit replacement. Heart (1998) 1.63
The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation. Chest (1990) 1.60
Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet (1984) 1.59
Cardioesophageal reflex: a mechanism for "linked angina" in patients with angiographically proven coronary artery disease. J Am Coll Cardiol (1996) 1.57
A randomised controlled crossover trial of nurse practitioner versus doctor led outpatient care in a bronchiectasis clinic. Thorax (2002) 1.56
Atrial septostomy in the treatment of severe pulmonary arterial hypertension. Thorax (2003) 1.56
Ventricular pacemaker upgrade: experience, complications and recommendations. Heart (1998) 1.55
Haemodynamic correction in multiorgan donation. Lancet (1992) 1.52
Performance status score: do patients and their oncologists agree? Br J Cancer (2003) 1.52
Coronary angiography in the presence of peripheral vascular disease: femoral or brachial/radial approach? Catheter Cardiovasc Interv (2000) 1.48
Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation. J Heart Lung Transplant (1993) 1.47
Incidence of spasm at the site of previous successful transluminal coronary angioplasty: effect of ergometrine maleate in consecutive patients. Br Heart J (1986) 1.43
Diagnosis of early cardiac transplant rejection by fall in evoked T wave amplitude measured using an externalized QT driven rate responsive pacemaker. Pacing Clin Electrophysiol (1991) 1.41
Mortality in the CHAOS trial. Lancet (1999) 1.41
Thermal and metabolic responses of women with high fat versus low fat body composition during exposure to 5 and 27 degrees C for 120 min. Aviat Space Environ Med (1999) 1.40
Is the secretion of atrial natriuretic peptide in man under neural control? Eur Heart J (2000) 1.39
Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol (2007) 1.39
A prospective randomized trial of complete atrioventricular transplantation versus ventricular transplantation with atrioplasty. J Heart Lung Transplant (1999) 1.38
Identification of coronary artery stenoses and poststenotic blood flow patterns using a miniature high-frequency epicardial transducer. Circulation (1994) 1.38
Use of lung biopsies in lung transplant recipients. Transplantation (1990) 1.37
Prevalence and prevention of glove perforation during cardiac operations. J Thorac Cardiovasc Surg (1993) 1.37
Heart and lung transplantation in patients with end stage lung disease. Br Med J (Clin Res Ed) (1987) 1.37
Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation (1988) 1.35
Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Cardiol (1996) 1.35
Survival and quality of life of cystic fibrosis patients before and after heart-lung transplantation. Transplant Proc (1991) 1.33
Left ventricular function in diabetes mellitus. I: Methodology, and prevalence and spectrum of abnormalities. Br Heart J (1981) 1.33
Balloon dilatation of tricuspid stenosis caused by carcinoid heart disease. Br Heart J (1990) 1.32
Heart disease in Asians in Britain. BMJ (1988) 1.29
The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study. Lancet (1987) 1.27
Risk factor analysis for the major hazards following heart transplantation--rejection, infection, and coronary occlusive disease. Transplantation (1991) 1.27
Incidence and aetiology of a raised hemidiaphragm after cardiopulmonary bypass. Thorax (1985) 1.25
Hypertrophic cardiomyopathy: a common disease with a good prognosis. Five year experience of a district general hospital. Br Heart J (1983) 1.25
Prospective study of health related quality of life before and after coronary artery bypass grafting: outcome at five years. Heart (1999) 1.25
Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin). Br Heart J (1987) 1.24
Upper gastrointestinal endoscopy in the elderly. Br Med J (Clin Res Ed) (1985) 1.23
Early experience of heart-lung transplantation. Arch Dis Child (1989) 1.20
Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation (2000) 1.19
Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. Br Heart J (1993) 1.17
Physiological left ventricular hypertrophy. Br Heart J (1984) 1.17
Study of trainer/trainee workload with special reference to the care of the elderly. J R Coll Gen Pract (1985) 1.17
Reduced endothelium-dependent relaxation of cystic fibrosis pulmonary arteries. Eur J Pharmacol (1989) 1.17
Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant (1995) 1.16
HIV and hepatitis C co-infection. Int J Clin Pract (2005) 1.16
Immunohistochemical demonstration of human cardiac innervation before and after transplantation. Circ Res (1990) 1.16
The haemodynamic significance of asymptomatic ST segment depression assessed by ambulatory pulmonary artery pressure monitoring. Br Heart J (1986) 1.15
Prospective study comparing quality of life before and after heart transplantation. Transplant Proc (1990) 1.15
Toxoplasmosis in cardiac transplantation. Br Med J (Clin Res Ed) (1986) 1.15
Selection and procurement of combined heart and lung grafts for transplantation. J Thorac Cardiovasc Surg (1988) 1.14
Echocardiographic features of malignant hypertension. Br Heart J (1981) 1.13
Significance of donor transmitted disease in cardiac transplantation. J Heart Transplant (1985) 1.13
Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation (1991) 1.13
Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer. Thorax (2005) 1.13
Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. Br Heart J (1990) 1.13
Selection and procurement of hearts for transplantation. Br Med J (Clin Res Ed) (1984) 1.13
Airway mucosal bioelectric potential difference in cystic fibrosis after lung transplantation. Am Rev Respir Dis (1989) 1.11